UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
___________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported): May 26, 2009
___________
CROWDGATHER,
INC.
(Exact
name of registrant as specified in Charter)
|
Nevada
|
|
000-
52143
|
|
20-2706319
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Commission
File No.)
|
|
(IRS
Employee
Identification
No.)
|
20300 Ventura Blvd. Suite
330, Woodland Hills, California 91364
(Address
of Principal Executive Offices)
(818)
435-2472
(Issuer
Telephone number)
______________________________________________________________________
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Share Exchange Act
(17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Share
Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Share
Exchange Act (17 CFR 240.13e-4(c))
|
On May
26, 2009, the Board of Directors of CrowdGather, Inc. (the “Registrant”)
appointed Chuck Timpe as a member of the Board of Directors of the
Registrant.
Chuck
Timpe is a seasoned director and financial executive and has served as a
director since 1998 for IPC-The Hospitalist Company (IPCM – NASDAQ) and as an
advisor to CrowdGather since October 2008. From June 2003 to November 2008,
Mr. Timpe served as the chief financial officer of Hythiam, Inc.
(HYTM—NASDAQ). Prior to joining Hythiam, Mr. Timpe was chief financial
officer, from its inception in February 1998 to June 2003, of Protocare, Inc., a
clinical research and pharmaceutical outsourcing company which merged with
Radiant Research, Inc. in March 2003. Previously, he was a principal in two
private healthcare management consulting firms he co-founded, chief financial
officer of National Pain Institute, treasurer and corporate controller for
American Medical International, Inc. (now Tenet Healthcare Corp.; THC—NYSE), and
a member of Arthur Andersen, LLP’s healthcare practice, specializing in public
company and hospital system audits. Mr. Timpe is currently a business
consultant. Mr. Timpe received his B.S. from University of Missouri, School
of Business and Public Administration, and is a certified public
accountant.
On May
26, 2009, and in connection with his appointment to the Board of Directors,
Mr. Timpe was granted 325,000 options to purchase shares of the
Registrant’s common stock at an exercise price of $0.86 per share. In October
2008, Mr. Timpe was granted 50,000 options to purchase shares of the
Registrant’s common stock in exchange for his role as an advisor to the
Registrant. Mr. Timpe does not own any shares of the Registrant’s
common stock.
Reference
is made to the Registrant’s press release dated May 27, 2009, filed hereto as
exhibit 99.1.
ITEM
8.01 Other Events.
We issued
a press release on May 27, 2009, in which we announced the appointment of Chuck
Timpe to the Board of Directors. A copy of such release is furnished
with this Current Report as Exhibit 99.1.
ITEM
9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit Number
|
|
Description
of Document
|
|
|
|
|
|
99.1
|
|
Press
Release dated May 27, 2009.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Company has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
CROWDGATHER,
INC.
|
|
|
|
|
|
By:
|
/s/
Sanjay Sabnani
|
|
|
|
|
Sanjay
Sabnani
|
|
|
|
Chief
Executive Officer, President,
Secretary,
Treasurer, and Director
|
|
|
|
|
|
Date: May
27, 2009
|
3